Clinical and Analytical Performance of DuritectTM: A Novel Blood-Based Autoantibody Diagnostic Sceening Platform for Alzheimer’s and Parkinson’s Diseases

Amyloid ß and Tau Oligomers Disrupt Blood-Brain Barrier in a Human Based in-vitro Microfluidic Neurovascular Unit Model

Accuracy of Plasma Biomarkers for Detecting Amyloid Beta Deposits in Participants With Alzheimer’s Disease in ASCENT-2 Clinical Trial of PRX012

CSF YKL-40 Level Predicts the Cognitive Progress of De Novo Parkinson’s Disease